Immunology 2 - Hypersensitivity & Autoimmune Diseases Flashcards
Type 1 Hypersensitivity:
- characteristics? [3]
- what is it responsible for? [1]
- Specific characteristics:
- response to challenge occurs immediately
- tends to increase in severity with repeated challenge
- predominantly mediated by lgE bound to mast cells
- Responsible for most “allergies”
- asthma
- eczema
- hayfever
Describe the pathophysiology of a type 1 hypersensitivity reaction [6]
- sensitisation
- mast cells primed with lgE
- re-exposure to antigen
- antigen binds to lgE associated with mast cells
- mast cells degranulate releasing:
- toxins (i.e. histamine)
- tryptase
- pro-inflammatory cytokines
- chemokines
- prostaglandins
- leukotrienes
- pro-imflammatory process stimulates and amplifies future responses
Describe tissue effects during the different phases of an allergic reaction:
- the early phase? [4]
- the late phase? [4]
- Early Phase:
- occurs within minutes of exposure to antigen
- occurs largely as a result of histamine and prostaglandins which results in:
- smooth muscle contraction
- increased vascular permeability
- Late Phase
- occurs over hours to days after exposure to antigen
- principally mediated through recruitment of T-cells and other immune cells to site
- results in:
- sustained smooth muscle contraction/hypertrophy
- tissue remodelling
What is anaphylaxis and describe its pathogenesis [6]
-
severe, systemic type I hypersensitivity
- widespread mast cell degranulation caused by systemic exposure to antigen (i.e. penicillin)
- vascular permeability is principle immediate danger:
- soft tissue swelling threatening airway
- loss of circulatory volume causing shock
- can be rapidly fatal
Type 2 Hypersensitivity
- causes of type 2 hypersensitivity? [2]
- what is it responsible for? [1]
- pathophysiology of type 2 hypersensitivity reaction? [4]
- caused by binding of antibodies directed against human cells
- lgG is the usual cause (sometimes IgM, IgA)
- common cause of autoimmune disease and an uncommon cause of allergy (drug associated haemolysis)
- pathophysiology:
- sensitisation
- opsonisation of cells
- cytotoxicity
- complement activation
- inflammation
- tissue destruction
Type 3 Hypersensitivity
- cause of type 3 hypersensitivity (what is it mediated by?) [1]
- what conditions does it cause? [2]
- complications of type 3 hypersensitivity? [4]
- mediated by immune complexes bound to soluble antigen
- cause of autoimmune disease and drug allergy
- complications:
- aggregate in small blood vessels resulting in
- direct occlusion
- complement activation
- perivascular inflammation
- aggregate in small blood vessels resulting in
Type 4 Hypersensitivity
- what is type 4 hypersensitivity mediated by? [1]
- when does it present? [1]
- mediated by the action of lymphocytes infiltrating area
- presents several days after exposure
Define the term autoimmune disease [1]
harmful inflammatory response directed against ‘self’ tissue by the adaptive immune response that can be either organ specific or systemic
Type 1 Diabetes
- definition? [1]
- what types of hypersensitivity are involved? [2]
- complications? [2]
- selective, autoimmune destruction of the pancreatic ß-cells
- often mix of Type Il & Type IV
- causes profound insulin deficiency and death if not treated with insulin replacement
Myasthenia Gravis
- Definition? [1]
- Cause? [2]
- syndrome of fatigable muscle weakness affecting limbs, respiratory system & head and neck
- caused by lgG antibody acting against acetylcholine receptor preventing signal transduction
Give 5 examples of systemic autoimmune diseases [5]
- Rheumatoid arthritis
- Systemic lupus erythematosus
- Inflammatory bowel disease
- Connective tissue disease
- Systemic vasculitis
Rheumatoid Arthritis
- signs & symptoms? [7]
- pathophysiology? [8]
- signs & symptoms:
- pulmonary nodules and fibrosis
- pericarditis & valvular inflammation
- small vessel vasculitis
- soft tissue nodules
- skin inflammation
- weight loss
- anaemia
- Pathophysiology
- Rheumatoid Factor is lgM and lgA directed against lgG Fc region which forms large immune complexes within synovial fluid
- Inflammation leads to release of PAD from inflammatory cells
- Alters variety of proteins by converting alanine to citrulline
- in RA, anti-citrullinated protein/peptide antibodies are common
- Amplification of inflammatory cascade
- Further chemoatraction of inflammatory cells into synovium:
- macrophages
- neutrophils
- lymphocytes
- Osteoclast activation and joint destruction
- Fibroblast activation and synovial hyperplasia
- Systemic inflammation
Treatment of Autoimmune Conditions: State the type of agent each of these drugs are and what they target:
- infliximab? [2]
- etanercept? [2]
- rituximab? [2]
-
Infliximab
- monoclonal antibody
- targets soluble cytokines
-
Etanercept
- soluble receptor
- targets soluble cytokines
-
Rituximab
- monoclonal antibody
- targets surface markers